| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-10587 |
BIX-01294 |
|
98.44% |
Unkown |
| HY-N0054 |
Osthole |
|
99.98% |
Unkown |
| HY-100201 |
A-196 |
Inhibitor |
98.76% |
Unkown |
| HY-150190 |
F5446 |
|
99.73% |
Unkown |
| HY-N6796 |
Manumycin A |
|
99.27% |
Unkown |
| HY-N0736 |
Coptisine chloride |
Inhibitor |
99.73% |
Unkown |
| HY-N0638 |
Dendrobine |
|
99.92% |
Unkown |
| HY-18340 |
(R)-CR8 |
|
99.52% |
Unkown |
| HY-107647 |
(S)-(+)-Dimethindene maleate |
Antagonist |
99.80% |
Unkown |
| HY-N0243 |
Theaflavin |
Inhibitor |
99.69% |
Unkown |
| HY-W027592 |
1H-1,2,4-Triazol-3-amine |
|
99.96% |
Unkown |
| HY-109582 |
ADT-OH |
|
98.55% |
Unkown |
| HY-20007 |
2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine |
|
99.78% |
Unkown |
| HY-77001 |
5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid |
|
99.99% |
Unkown |
| HY-23033 |
Tempone-H |
|
98.0% |
Unkown |
| HY-N0440 |
Germacrone |
|
99.76% |
Unkown |
| HY-20006 |
2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine (hydrochlortde) |
|
99.99% |
Unkown |
| HY-18340A |
(R)-CR8 trihydrochloride |
|
99.37% |
Unkown |
| HY-136464 |
β-catenin-IN-2 |
Inhibitor |
99.55% |
Unkown |
| HY-41404 |
Piperonylic acid |
Inhibitor |
99.94% |
Unkown |
| HY-12783A |
SCH 50911 |
Antagonist |
99.62% |
Unkown |
| HY-107565 |
2-Pyridylethylamine hydrochloride |
Agonist |
98.61% |
Unkown |
| HY-126254 |
BI-4924 |
|
99.55% |
Unkown |
| HY-101063 |
Amthamine dihydrobromide |
Agonist |
99.64% |
Unkown |
| HY-42476 |
Tolvaptan Impurity |
|
99.92% |
Unkown |
| HY-N0891 |
Tubeimoside II |
|
99.90% |
Unkown |
| HY-128147 |
MetAP-2-IN-6 |
Inhibitor |
99.55% |
Unkown |
| HY-N0392 |
Polygalasaponin F |
|
99.85% |
Unkown |
| HY-W040584 |
1H,1'H-2,2'-Biimidazole |
|
/ |
Unkown |
| HY-148825 |
NP10679 |
|
98.40% |
Unkown |
| HY-B0303AS1 |
Diphenhydramine-d5 hydrochloride |
Antagonist |
99.84% |
Unkown |
| HY-B1483 |
Methapyrilene hydrochloride |
Inhibitor |
99.88% |
Unkown |
| HY-108239 |
BIX-01294 trihydrochloride |
|
99.68% |
Unkown |
| HY-103070 |
PythiDC |
Inhibitor |
99.05% |
Unkown |
| HY-NP155A |
Histone H1 (calf thymus) |
|
/ |
Unkown |
| HY-W014941 |
(R)-(-)-α-Methylhistamine dihydrochloride |
Agonist |
99.76% |
Unkown |
| HY-I0896 |
P-Toluenesulfonic Acid (3S,5R)-5-(2,4-Difluorophenyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]oxolan-3-ylmethyl Ester |
|
99.94% |
Unkown |
| HY-B0303AS |
Diphenhydramine-d6 hydrochloride |
Antagonist |
99.30% |
Unkown |
| HY-103149 |
SB-216641A |
Antagonist |
98.04% |
Unkown |
| HY-101232 |
Tiotidine |
Antagonist |
99.28% |
Unkown |
| HY-12394 |
Dothiepin |
Inhibitor |
98.50% |
Unkown |
| HY-N9331 |
Cimicifugoside H-1 |
|
99.83% |
Unkown |
| HY-B1047 |
Carsalam |
|
99.91% |
Unkown |
| HY-W002199 |
6:2 Fluorotelomer alcohol |
|
99.96% |
Unkown |
| HY-105014 |
Tecastemizole |
Antagonist |
99.22% |
Unkown |
| HY-13317S |
Oseltamivir-d3 |
Inhibitor |
99.9% |
Unkown |
| HY-145725A |
Baliforsen |
Inhibitor |
98.12% |
Unkown |
| HY-162231 |
HY-078020 |
Antagonist |
98.87% |
Unkown |
| HY-B1808 |
Triprolidine |
Antagonist |
98.84% |
Unkown |
| HY-N2495A |
(R)-Isomucronulatol |
|
99.77% |
Unkown |
| HY-N3953 |
Glucosyringic acid |
|
99.62% |
Unkown |
| HY-P2480 |
Histone H1-derived Peptide |
|
99.92% |
Unkown |
| HY-W007685 |
Methyl 1H-1,2,4-triazole-5-carboxylate |
|
97.50% |
Unkown |
| HY-100657 |
meta-Fexofenadine |
|
98.63% |
Unkown |
| HY-101052 |
HTMT dimaleate |
Agonist |
99.55% |
Unkown |
| HY-126136 |
ML303 |
Antagonist |
99.28% |
Unkown |
| HY-131069A |
MBX2329 |
Inhibitor |
99.90% |
Unkown |
| HY-14328 |
Sonepiprazole |
Antagonist |
98.43% |
Unkown |
| HY-17042S1 |
Cetirizine-d8 |
Antagonist |
96.46% |
Unkown |
| HY-17043S1 |
Loratadine-d5 |
Agonist |
99.96% |
Unkown |
| HY-175469 |
VNT-101 |
Inhibitor |
99.51% |
Unkown |
| HY-78924 |
N-Boc-D-prolinol |
|
≥97.0% |
Unkown |
| HY-W012991 |
3-Mercapto-1,2,4-triazole |
|
99.78% |
Unkown |
| HY-B1008S |
4-Aminobenzoic acid-d4 |
|
99.53% |
Unkown |
| HY-W113615 |
4-Phenyl-1H-1,2,3-triazole |
Inhibitor |
99.35% |
Unkown |
| HY-Z7147 |
Efinaconazole analogue-1 |
Control |
98.67% |
Unkown |
| HY-14541S |
Olanzapine-d3 |
|
99.78% |
Unkown |
| HY-181527S |
N-(4-((3-Methoxy-4-(1-(methyl-d3)-1H-1,2,4-triazol-3-yl)pyridin-2-yl)amino)-5-propionylpyridin-2-yl)cyclopropanecarboxamide |
|
99.93% |
Unkown |
| HY-B0527AS |
Amitriptyline-d6 hydrochloride |
|
99.93% |
Unkown |
| HY-100238 |
Antihistamine-1 |
Inhibitor |
99.08% |
Unkown |
| HY-15647 |
BRD9539 |
Inhibitor |
99.73% |
Unkown |
| HY-181938S |
(S)-N-(4-((3-Methoxy-4-(2-methyl-2H-1,2,3-triazol-4-yl)pyridin-2-yl)amino)-5-propionylpyridin-2-yl)spiro[2.2]pentane-1-carboxamide-d3 |
|
/ |
Unkown |
| HY-N7503 |
Psoralenoside |
Inhibitor |
99.84% |
Unkown |
| HY-P1382A |
Rac1 Inhibitor W56 TFA |
Inhibitor |
99.92% |
Unkown |
| HY-W008353 |
H-1-Nal-OH |
|
99.49% |
Unkown |
| HY-W016622 |
Watermelon ketone |
|
99.95% |
Unkown |
| HY-W089929 |
2-(3-(Pyridin-4-yl)-1H-1,2,4-triazol-5-yl)pyridine |
|
/ |
Unkown |
| HY-W112721 |
1H,1'H-4,4'-Bipyrazole |
|
99.62% |
Unkown |
| HY-N12285 |
6-Methoxy-2-(2-phenylethyl)chromone |
|
99.58% |
Unkown |
| HY-N7707 |
Sandacanol |
Inducer |
99.29% |
Unkown |
| HY-W411827 |
1H,1H,2H,2H-Perfluorohexanesulfonic acid |
|
99.9% |
Unkown |
| HY-WAA0156 |
1-(Pyrrolidin-3-yl)-1H-1,2,4-triazole oxalate |
|
98.0% |
Unkown |
| HY-131059 |
CBS1117 |
Inhibitor |
99.76% |
Unkown |
| HY-100999 |
(R)-(-)-α-Methylhistamine dihydrobromide |
Agonist |
≥98.0% |
Unkown |
| HY-101179 |
Tesmilifene fumarate |
Antagonist |
99.85% |
Unkown |
| HY-105542 |
Niaprazine |
Antagonist |
99.67% |
Unkown |
| HY-13710 |
Dimethindene |
Inhibitor |
98.94% |
Unkown |
| HY-137334 |
Neuraminidase-IN-1 |
Inhibitor |
98.93% |
Unkown |
| HY-A0015A |
(Rac)-Bepotastine besilate |
Inhibitor |
99.52% |
Unkown |
| HY-RS16034 |
ZFC3H1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W006393 |
[2,2'-Bipyridine]-6,6'(1H,1'H)-dione |
|
/ |
Unkown |
| HY-W012383 |
1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone |
|
99.86% |
Unkown |
| HY-W023897 |
3-(1H-1,2,4-Triazol-1-yl)benzoic Acid |
|
/ |
Unkown |
| HY-W042692 |
5-Pyridin-4-yl-1H-1,2,4-triazol-3-amine |
|
/ |
Unkown |
| HY-W128191 |
1H,1'H-2,2'-Bipyrrole |
|
/ |
Unkown |
| HY-W543267 |
1,3,5-Tri(1H-1,2,3-triazol-5-yl)benzene |
|
/ |
Unkown |
| HY-119832B |
(S)-Setastine |
Antagonist |
/ |
Unkown |
| HY-180269 |
Anti-Influenza agent 10 |
Inhibitor |
/ |
Unkown |
| HY-N10765 |
Salvinolone |
Inhibitor |
98.51% |
Unkown |
| HY-W073147 |
1H,1H,2H,2H-Perfluoro-1-decanol |
Control |
98.73% |
Unkown |
| HY-B0157AS |
Ketotifen-d3 fumarate |
Inhibitor |
99.23% |
Unkown |
| HY-111501 |
H4R antagonist 1 |
Antagonist |
99.82% |
Unkown |
| HY-12532S |
Astemizole-d3 |
|
97.78% |
Unkown |
| HY-107647A |
(R)-(+)-Dimethindene maleate |
Antagonist |
99.50% |
Unkown |
| HY-108938 |
SDZ285428 |
Inhibitor |
98.00% |
Unkown |
| HY-123304 |
MBX2546 |
Inhibitor |
99.9% |
Unkown |
| HY-12349 |
H1PVAT |
Inhibitor |
96.40% |
Unkown |
| HY-129150 |
Ganoderic acid TR |
Inhibitor |
98.0% |
Unkown |
| HY-131256 |
Cetirizine Impurity C |
Antagonist |
/ |
Unkown |
| HY-131256A |
Cetirizine Impurity C dihydrochloride |
Antagonist |
99.95% |
Unkown |
| HY-131579 |
Deschloro Cetirizine dihydrochloride |
|
99.44% |
Unkown |
| HY-136587 |
Oxomemazine |
Antagonist |
99.18% |
Unkown |
| HY-141422A |
4,4-Diphenylbutylamine hydrochloride |
Antagonist |
99.00% |
Unkown |
| HY-156049 |
MG-H1 |
|
/ |
Unkown |
| HY-17042S |
Cetirizine-d4 |
Antagonist |
99.10% |
Unkown |
| HY-30234S |
Clemizole-d4 |
|
99.82% |
Unkown |
| HY-41749 |
1H-1,2,3-Triazole-4,5-dicarboxylic acid |
|
/ |
Unkown |
| HY-47228 |
KB-5492 free base |
Inhibitor |
99.02% |
Unkown |
| HY-A0077S1 |
Perphenazine-d4 |
|
98.83% |
Unkown |
| HY-B0188S |
Mianserin-d3 |
|
/ |
Unkown |
| HY-B0298AS |
Clemastine-d5 fumarate |
|
99.48% |
Unkown |
| HY-B0539S3 |
Desloratadine-d5 |
Antagonist |
99.74% |
Unkown |
| HY-B0725S |
Doxepin-d3 hydrochloride |
|
99.88% |
Unkown |
| HY-B0781S |
Promethazine-d4 hydrochloride |
Antagonist |
95.35% |
Unkown |
| HY-B0814S1 |
Levocetirizine-d4 |
|
99.41% |
Unkown |
| HY-N2735 |
7,3',4'-Trihydroxy-3-benzyl-2H-chromene |
Inhibitor |
95.47% |
Unkown |
| HY-P1837 |
Influenza HA (518-526) |
Inhibitor |
98.28% |
Unkown |
| HY-RS05946 |
H1-10 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05947 |
H1-2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-U00267 |
Thiazinamium chloride |
Inducer |
97.44% |
Unkown |
| HY-W010130 |
7-Hydroxy-3,4-dihydro-2(1H)-quinolinone |
Inhibitor |
99.96% |
Unkown |
| HY-W016149 |
4,5-Dichloro-3H-1,2-dithiol-3-one |
Inhibitor |
98.0% |
Unkown |
| HY-W075138 |
1,4-Di(4H-1,2,4-triazol-4-yl)benzene |
|
/ |
Unkown |
| HY-W075154 |
2-(1H-1,2,4-Triazol-1-yl)benzene-1,3,5-tricarboxylic acid |
|
/ |
Unkown |
| HY-W075250 |
3,3',5,5'-Tetramethyl-1H,1'H-4,4'-bipyrazole |
|
/ |
Unkown |
| HY-W075298 |
4-(4H-1,2,4-Triazol-4-yl)benzoic acid |
|
/ |
Unkown |
| HY-W075569 |
Tris(4-(4H-1,2,4-triazol-4-yl)phenyl)amine |
|
/ |
Unkown |
| HY-W103735 |
3,5-Diphenyl-4H-1,2,4-triazole |
|
/ |
Unkown |
| HY-W112477 |
4-(4H-1,2,4-Triazol-4-yl)phenol |
|
/ |
Unkown |
| HY-W516880 |
Desmethylastemizole |
|
98.26% |
Unkown |
| HY-101830 |
Wy 49051 |
Antagonist |
98.70% |
Unkown |
| HY-105542R |
Niaprazine (Standard) |
Antagonist |
99.62% |
Unkown |
| HY-122508 |
Hydroxyebastine |
|
97.33% |
Unkown |
| HY-RS16280 |
FAM-labeled P3H1 Human Pre-designed siRNA Set A |
|
/ |
Unkown |
| HY-U00084 |
SUN 1334H |
Antagonist |
98.29% |
Unkown |
| HY-W329835S |
2-((1H-1,2,4-Triazol-1-yl)methyl)-4-(4-chlorophenyl)-2-phenylbutanenitrile-d5 |
|
98.18% |
Unkown |
| HY-115507 |
NMac1 |
|
/ |
Unkown |
| HY-156786 |
TLD-1433 |
|
/ |
Unkown |
| HY-100858 |
PP7 |
Inhibitor |
/ |
Unkown |
| HY-107977 |
IDH1 Inhibitor 3 |
Inhibitor |
/ |
Unkown |
| HY-121356S |
Carebastine-d5 |
Antagonist |
/ |
Unkown |
| HY-121356S1 |
Carebastine-d5 Methyl Ester |
Antagonist |
/ |
Unkown |
| HY-132698S |
2-Amino-4-chloro-N-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]benzamide-d3 |
|
/ |
Unkown |
| HY-132733S |
1H-1-Ethyl-d5 candesartan |
|
/ |
Unkown |
| HY-135180S |
1H-1-Ethyl Candesartan Cilexetil-d5 |
|
/ |
Unkown |
| HY-141723S |
(4R,5R)-5-(2,4-Difluorophenyl)-4-methyl-5-(1H-1,2,4-triazol-1-ylmethyl)-2-oxazolidinone-d3 |
|
/ |
Unkown |
| HY-141726S |
rel-(αR,βR)-β-(2,4-Difluorophenyl)-β-hydroxy-α-methyl-1H-1,2,4-triazole-1-butanoic acid-d3 |
|
/ |
Unkown |
| HY-17043S |
Loratadine-d4 |
Agonist |
/ |
Unkown |
| HY-A0019S |
Paliperidone-d4 |
Antagonist |
/ |
Unkown |
| HY-B0524AS |
Betahistine-d3 dihydrochloride |
Modulator |
99.0% |
Unkown |
| HY-B0539S |
Desloratadine-d4 |
Antagonist |
/ |
Unkown |
| HY-B0539S1 |
Desloratadine-d9 |
Antagonist |
/ |
Unkown |
| HY-B0814S |
Levocetirizine-d4 dihydrochloride |
Antagonist |
99.39% |
Unkown |
| HY-B1589S |
(±)-Carbinoxamine-d6 |
|
/ |
Unkown |
| HY-W013775S |
N-Desmethyl ofloxacin-d8 |
|
/ |
Unkown |
| HY-W098127S |
Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate-d2 |
|
/ |
Unkown |
| HY-100280 |
Pirolate |
Antagonist |
/ |
Unkown |
| HY-100570 |
KF15766 |
Antagonist |
/ |
Unkown |
| HY-100657S |
Meta-Fexofenadine-d6 |
|
/ |
Unkown |
| HY-100660A |
Cetirizine Impurity B dihydrochloride |
|
/ |
Unkown |
| HY-103216A |
RWJ52353 hydrochloride |
Agonist |
/ |
Unkown |
| HY-105395 |
BCX-1898 |
Inhibitor |
/ |
Unkown |
| HY-10564S |
Sarpogrelate-d3 hydrochloride |
Antagonist |
/ |
Unkown |
| HY-10564S1 |
Sarpogrelate-d4 hydrochloride |
Antagonist |
/ |
Unkown |
| HY-106465 |
Proterguride |
|
/ |
Unkown |
| HY-106507 |
Batoprazine |
Agonist |
/ |
Unkown |
| HY-106924 |
DF-1111301 |
|
/ |
Unkown |
| HY-106957 |
Efletirizine |
Antagonist |
/ |
Unkown |
| HY-107495 |
Betahistine EP Impurity C |
Modulator |
98.38% |
Unkown |
| HY-107559 |
GT-2016 |
Antagonist |
/ |
Unkown |
| HY-108411S |
Emedastine-13C,d3 fumarate |
Antagonist |
/ |
Unkown |
| HY-114660 |
9,11-Methane-epoxy prostaglandin F1α |
|
/ |
Unkown |
| HY-115507A |
(Z)-NMac1 |
Inhibitor |
/ |
Unkown |
| HY-116182 |
RO5487624 |
Inhibitor |
/ |
Unkown |
| HY-117046 |
AVN-101 |
|
/ |
Unkown |
| HY-118807A |
Mepyramine hydrochloride |
|
/ |
Unkown |
| HY-119213 |
BMY-27709 |
Inhibitor |
/ |
Unkown |
| HY-119854 |
Atiprosine |
Antagonist |
/ |
Unkown |
| HY-119913 |
Dacemazine |
Antagonist |
/ |
Unkown |
| HY-119913A |
Dacemazine hydrochloride |
|
/ |
Unkown |
| HY-119995 |
Chloropyramine |
|
/ |
Unkown |
| HY-122483 |
Diethyl pyimDC |
Inhibitor |
/ |
Unkown |
| HY-123230S |
Trifloxystrobin-d6 |
Inhibitor |
/ |
Unkown |
| HY-123597 |
NSC 109555 |
|
/ |
Unkown |
| HY-124305 |
ML395 |
|
/ |
Unkown |
| HY-124356 |
Alcaftadine carboxylic acid |
|
/ |
Unkown |
| HY-124356AS |
Alcaftadine carboxylic acid-d3 sodium |
|
/ |
Unkown |
| HY-124420 |
MLS-0322825 |
Inhibitor |
/ |
Unkown |
| HY-125209A |
TH5427 hydrochloride |
|
/ |
Unkown |
| HY-12752BS |
Alimemazine-d6 hydrochloride |
Agonist |
/ |
Unkown |
| HY-129152 |
Ganoderic acid T-N |
Inhibitor |
/ |
Unkown |
| HY-129482 |
Detoxin D1 |
|
/ |
Unkown |
| HY-131274 |
Fexofenadine Impurity F |
|
/ |
Unkown |
| HY-131983 |
Neuraminidase-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-132286 |
2-PADQZ |
|
90.00% |
Unkown |
| HY-13317S1 |
Oseltamivir-d3-1 |
|
/ |
Unkown |
| HY-13317S4 |
Oseltamivir-d3 hydrochloride |
|
/ |
Unkown |
| HY-133567 |
SET7-IN-DC21 |
Inhibitor |
/ |
Unkown |
| HY-133727 |
Terfenadine N-oxide |
|
/ |
Unkown |
| HY-13511AS |
Rupatadine-d4 fumarate |
|
/ |
Unkown |
| HY-13511S |
Rupatadine-d6 D-tartrate |
|
/ |
Unkown |
| HY-135180 |
1H-1-Ethyl Candesartan Cilexetil |
|
/ |
Unkown |
| HY-137566 |
Cucumarioside H |
|
/ |
Unkown |
| HY-139991 |
Neuraminidase-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-141878 |
di-Ellipticine-RIBOTAC |
|
/ |
Unkown |
| HY-141878A |
di-Ellipticine-RIBOTAC TFA |
|
/ |
Unkown |
| HY-14277 |
Levocabastine |
Antagonist |
/ |
Unkown |
| HY-142918 |
μ opioid receptor agonist 1 |
Agonist |
/ |
Unkown |
| HY-143494 |
RSV/IAV-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-143762 |
Cap-dependent endonuclease-IN-12 |
Inhibitor |
/ |
Unkown |
| HY-143907S |
Atorvastatin EP impurity H-d5 |
|
/ |
Unkown |
| HY-144668 |
RdRP-IN-4 |
Inhibitor |
/ |
Unkown |
| HY-14541S2 |
Olanzapine-d8 |
|
99.9% |
Unkown |
| HY-146033 |
HPV18-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-147336 |
Desmethylazelastine |
|
/ |
Unkown |
| HY-147881 |
Anti-Influenza agent 3 |
Inhibitor |
/ |
Unkown |
| HY-147974 |
HSP90-IN-14 |
Inhibitor |
/ |
Unkown |
| HY-149034 |
Influenza A virus-IN-8 |
Inhibitor |
/ |
Unkown |
| HY-149088 |
Neuraminidase-IN-16 |
Inhibitor |
/ |
Unkown |
| HY-149247 |
Antipsychotic agent-2 |
|
/ |
Unkown |
| HY-149261 |
H1k |
|
/ |
Unkown |
| HY-14939A |
Vapitadine hydrochloride |
Antagonist |
/ |
Unkown |
| HY-14988 |
I-A09 |
Inhibitor |
/ |
Unkown |
| HY-149975 |
AMPA receptor modulator-4 |
Activator |
/ |
Unkown |
| HY-150685 |
Topo I/COX-2-IN-1 |
|
/ |
Unkown |
| HY-151103 |
Neuraminidase-IN-10 |
Inhibitor |
/ |
Unkown |
| HY-151104 |
Neuraminidase-IN-11 |
Inhibitor |
/ |
Unkown |
| HY-151967 |
Anti-IAV agent 1 |
Inhibitor |
/ |
Unkown |
| HY-155110 |
Antiviral agent 34 |
|
/ |
Unkown |
| HY-155468 |
AG8.0 |
|
/ |
Unkown |
| HY-155476 |
Influenza virus-IN-8 |
Inhibitor |
/ |
Unkown |
| HY-155731 |
Antiviral agent 35 |
Inhibitor |
/ |
Unkown |
| HY-156981 |
Pirdonium bromide |
|
/ |
Unkown |
| HY-157249 |
Antiviral agent 43 |
Inhibitor |
/ |
Unkown |
| HY-157426 |
GSPT1 degrader-3 |
Degrader |
/ |
Unkown |
| HY-161376 |
M4K2281 |
Inhibitor |
/ |
Unkown |
| HY-161902 |
MI-1904 |
Inhibitor |
/ |
Unkown |
| HY-162242 |
Cap-dependent endonuclease-IN-27 |
Inhibitor |
/ |
Unkown |
| HY-162492 |
Influenza A virus-IN-14 |
Inhibitor |
/ |
Unkown |
| HY-162801 |
Neuraminidase-IN-21 |
Inhibitor |
/ |
Unkown |
| HY-162983 |
KRAS inhibitor-36 |
Inhibitor |
/ |
Unkown |
| HY-164010 |
SUN-1334H free base |
Inhibitor |
/ |
Unkown |
| HY-167850 |
Noberastine maleate |
Antagonist |
/ |
Unkown |
| HY-167897 |
UR-AK49 |
Agonist |
/ |
Unkown |
| HY-17042AS |
Cetirizine-d4 dihydrochloride |
Inhibitor |
/ |
Unkown |
| HY-17042AS1 |
Cetirizine-d8 dihydrochloride |
Antagonist |
99.64% |
Unkown |
| HY-17042B |
(S)-Cetirizine dihydrochloride |
Antagonist |
/ |
Unkown |
| HY-170440 |
ATV2301 |
Inhibitor |
/ |
Unkown |
| HY-170789 |
H1R ligand-1 |
Ligand |
/ |
Unkown |
| HY-172332 |
H1L1A1B3 |
Activator |
/ |
Unkown |
| HY-172339 |
4-AcO-DALT hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-175532 |
M4 mAChR Modulator-2 |
Activator |
/ |
Unkown |
| HY-175737 |
α-synuclein-IN-16 |
Inhibitor |
/ |
Unkown |
| HY-175808 |
VF-57a |
Inhibitor |
/ |
Unkown |
| HY-178285 |
VHR-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-178292 |
VHR-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-178294 |
VHR-IN-4 |
Inhibitor |
/ |
Unkown |
| HY-178295 |
VHR-IN-5 |
Inhibitor |
/ |
Unkown |
| HY-178296 |
VHR-IN-6 |
Inhibitor |
/ |
Unkown |
| HY-178297 |
VHR-IN-7 |
Inhibitor |
/ |
Unkown |
| HY-178301 |
VHR-IN-9 |
Inhibitor |
/ |
Unkown |
| HY-178303 |
VHR-IN-8 |
Inhibitor |
/ |
Unkown |
| HY-178727 |
R 58639 |
Antagonist |
/ |
Unkown |
| HY-178885 |
(S)-4-(4-(2-(Methylamino)propyl)phenoxy)butanoic acid TFA |
|
/ |
Unkown |
| HY-181630S |
C-(1,1-Dimethylpropyl) N-[2-[[2-[7-[[2-deoxy-2-(sulfoamino)-α-D-glucopyranosyl]oxy]-2-oxo-2H-1-benzopyran-4-yl]acetyl]amino]ethyl]carbamate-d4 |
|
/ |
Unkown |
| HY-181632S |
1,1-Dimethylpentyl N-[2-[[2-[7-[[2-(acetylamino)-2-deoxy-α-D-glucopyranosyl]oxy]-2-oxo-2H-1-benzopyran-4-yl]acetyl]amino]ethyl]carbamate-d4 |
|
/ |
Unkown |
| HY-181633S |
1,1-Dimethylbutyl N-[2-[[2-[7-[[2-(acetylamino)-2-deoxy-α-D-glucopyranosyl]oxy]-2-oxo-2H-1-benzopyran-4-yl]acetyl]amino]ethyl]carbamate-d4 |
|
/ |
Unkown |
| HY-181785 |
Influenza A virus-IN-18 |
Inhibitor |
/ |
Unkown |
| HY-182246 |
MC2050 |
Inhibitor |
/ |
Unkown |
| HY-182296 |
SCH 79687 |
Antagonist |
/ |
Unkown |
| HY-182439 |
AZD3778 |
Inhibitor |
/ |
Unkown |
| HY-182736 |
YM-344484 |
|
/ |
Unkown |
| HY-23188 |
Loratadine-d5-1 |
|
/ |
Unkown |
| HY-402545 |
(-)-Brompheniramine |
Antagonist |
99.67% |
Unkown |
| HY-A0015S |
Bepotastine-d6 besylate |
Antagonist |
/ |
Unkown |
| HY-A0027AS |
Fenspiride-d5 |
|
/ |
Unkown |
| HY-A0069AS |
Doxylamine-d5 |
|
/ |
Unkown |
| HY-A0069S |
Doxylamine-d5 succinate |
|
≥98.0% |
Unkown |
| HY-A0178 |
Isothipendyl |
Antagonist |
/ |
Unkown |
| HY-A0178A |
Isothipendyl hydrochloride |
Antagonist |
/ |
Unkown |
| HY-A0188 |
Norzine dimalate |
|
/ |
Unkown |
| HY-B0349S |
Meclizine-d8 |
|
/ |
Unkown |
| HY-B0352S2 |
Mirtazapine-d4 |
Antagonist |
/ |
Unkown |
| HY-B0352S3 |
Mirtazapine-d4 hydrochloride |
Antagonist |
/ |
Unkown |
| HY-B0426AS2 |
Olopatadine-d6 hydrochloride |
|
/ |
Unkown |
| HY-B0462AS |
Azelastine-13C,d3 |
|
/ |
Unkown |
| HY-B0462B |
(S)-Azelastine hydrochloride |
|
/ |
Unkown |
| HY-B0462C |
(R)-Azelastine hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-B0462S |
Azelastine-13C,d3 hydrochloride |
|
/ |
Unkown |
| HY-B0524AS1 |
Betahistine-13C,d3 dihydrochloride |
Modulator |
/ |
Unkown |
| HY-B0539S2 |
Desloratadine-3,3,5,5-d4 |
Antagonist |
/ |
Unkown |
| HY-B0539S4 |
Desloratadine-d4 hydrobromide |
Antagonist |
/ |
Unkown |
| HY-B0548AS |
Hydroxyzine-d4 dihydrochloride |
Antagonist |
/ |
Unkown |
| HY-B0548AS1 |
Hydroxyzine-d4' dihydrochloride |
Antagonist |
98.0% |
Unkown |
| HY-B0548AS2 |
Hydroxyzine-d8 dihydrochloride |
Antagonist |
/ |
Unkown |
| HY-B0548S1 |
Hydroxyzine D8 |
Antagonist |
99.0% |
Unkown |
| HY-B0640S |
Epinastine-13C,d3 hydrobromide |
|
/ |
Unkown |
| HY-B0674S |
Ebastine-d5 |
Antagonist |
/ |
Unkown |
| HY-B0674S1 |
Ebastine-d6 |
Antagonist |
/ |
Unkown |
| HY-B0781S1 |
Promethazine-d3 hydrochloride |
Antagonist |
/ |
Unkown |
| HY-B0801AS |
Fexofenadine-d10 hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-B0801S2 |
Fexofenadine-d3 |
|
/ |
Unkown |
| HY-B1296S1 |
Promethazine-d4 |
Antagonist |
/ |
Unkown |
| HY-B1317A |
Thonzylamine hydrochloride |
Antagonist |
/ |
Unkown |
| HY-B1589AS |
Carbinoxamine-d6 maleate |
Antagonist |
/ |
Unkown |
| HY-B1658BS |
Frovatriptan-d3 succinate |
Agonist |
/ |
Unkown |
| HY-B2101 |
Thenalidine |
Antagonist |
/ |
Unkown |
| HY-B2168S |
Mequitazine-d8 hydrobromide |
Antagonist |
/ |
Unkown |
| HY-D1507 |
1-[3-(Succinimidyloxycarbonyl)benzyl]-4-[2-(3,4-dihydro-2H-1-benzopyran-6-yl)-5-oxazolyl]pyridinium bromide |
|
/ |
Unkown |
| HY-N0224A |
Goitrin |
Inhibitor |
99.66% |
Unkown |
| HY-N0392R |
Polygalasaponin F (Standard) |
Inhibitor |
/ |
Unkown |
| HY-N10605 |
Maniwamycin E |
Inhibitor |
/ |
Unkown |
| HY-N10843 |
4-O-Methylepisappanol |
Inhibitor |
/ |
Unkown |
| HY-N10856 |
2H-1-Benzopyran-2-one, 6-[(1R,2S)-2,3-dihydroxy-1-methoxy-3-methylbutyl]-7-methoxy- |
|
/ |
Unkown |
| HY-N12708 |
23-O-β-D-Glucopyranosyl-20-isoveratramine |
|
/ |
Unkown |
| HY-N12728 |
Heteroclitin G |
|
/ |
Unkown |
| HY-N15215 |
Antiviral agent 64 |
Inhibitor |
/ |
Unkown |
| HY-N15217 |
Antiviral agent 65 |
Inhibitor |
/ |
Unkown |
| HY-N16425 |
Mitorubrin |
Control |
/ |
Unkown |
| HY-N16441 |
Pulvic acid |
Inhibitor |
/ |
Unkown |
| HY-N17236 |
Forsyshiyanine A |
Inhibitor |
/ |
Unkown |
| HY-N17299 |
Periplocoside H1 |
|
/ |
Unkown |
| HY-N17641 |
3,4,-Dihydro-5-methoxyl-6-methyl-2-phenyl-2H-1-benzopyran-7-ol |
|
/ |
Unkown |
| HY-N17850 |
5-Hydroxy-6,7-dimethoxyflavone |
|
/ |
Unkown |
| HY-N17963 |
Cappariloside A |
Inhibitor |
/ |
Unkown |
| HY-N17983 |
Hemsloside H1 |
|
/ |
Unkown |
| HY-N19715 |
Asperosaponin H1 |
|
/ |
Unkown |
| HY-N2264 |
Wulignan A1 |
|
99.05% |
Unkown |
| HY-N7915 |
Nepasaikosaponin K |
Inhibitor |
/ |
Unkown |
| HY-N9019 |
1,4-Epidioxybisabola-2,10-dien-9-one |
Inhibitor |
/ |
Unkown |
| HY-P10361 |
Temporin-GHc |
Inhibitor |
/ |
Unkown |
| HY-P10386 |
155H1 |
Inhibitor |
/ |
Unkown |
| HY-P10706 |
Ac-ILVAGK-NH2 |
|
/ |
Unkown |
| HY-P10975 |
P9R |
Inhibitor |
/ |
Unkown |
| HY-P11089 |
TP53 neoepitope |
Substrate |
/ |
Unkown |
| HY-P11145 |
Influenza HA (529-537) |
|
/ |
Unkown |
| HY-P1382 |
Rac1 Inhibitor W56 |
Inhibitor |
/ |
Unkown |
| HY-P1906 |
[pThr3]-CDK5 Substrate |
|
/ |
Unkown |
| HY-P1906A |
[pThr3]-CDK5 Substrate TFA |
|
/ |
Unkown |
| HY-P3745 |
H1-7 (histone H1 phosphorylation site), PKA Substrate |
|
/ |
Unkown |
| HY-P5616 |
Maximin H1 |
Inhibitor |
/ |
Unkown |
| HY-P5673 |
Bombinin H1 |
Inhibitor |
/ |
Unkown |
| HY-RS02806 |
CLIC4 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04082 |
DYNC1H1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS04086 |
DYNC2H1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05898 |
GTF2H1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05944 |
H1-0 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05945 |
H1-1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05948 |
H1-3 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05949 |
H1-4 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05950 |
H1-5 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05951 |
H1-6 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05952 |
H1-7 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05953 |
H1-8 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS09813 |
OR2H1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS09938 |
P3H1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS11777 |
RC3H1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS12009 |
RLN1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS14037 |
SUPT4H1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS14051 |
SUV39H1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS15692 |
VPS45 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-W002957 |
4-(1H-1,2,4-triazol-1-yl)benzoic acid |
|
/ |
Unkown |
| HY-W021499 |
2-(3-Methyl-1H-1,2,4-triazol-5-yl)pyridine |
|
/ |
Unkown |
| HY-W062109S |
Olopatadine-d6 |
|
/ |
Unkown |
| HY-W074655 |
4,4′,4′′-(1,3,5-Benzenetriyl)tris[1H-1,2,3-triazole-1-acetic acid] |
|
/ |
Unkown |
| HY-W075088 |
1,1'-Diethyl-1H,1'H-2,2'-biimidazole |
|
/ |
Unkown |
| HY-W075114 |
1,3,5-Tris(4-(4H-1,2,4-triazol-4-yl)phenoxy)benzene |
|
/ |
Unkown |
| HY-W075127 |
1,4-Bis((1H-1,2,4-triazol-1-yl)methyl)benzene |
|
/ |
Unkown |
| HY-W075135 |
1,4-Di(1H-1,2,4-triazol-1-yl)benzene |
|
/ |
Unkown |
| HY-W075152 |
2-((1H-1,2,4-Triazol-1-yl)methyl)benzoic acid |
|
/ |
Unkown |
| HY-W075155 |
2-(1H-1,2,4-Triazol-1-yl)benzoic acid |
|
/ |
Unkown |
| HY-W075194 |
2,5-Di(1H-1,2,4-triazol-1-yl)terephthalic acid |
|
/ |
Unkown |
| HY-W075212 |
2,6-Di(1H-1,2,4-triazol-1-yl)pyridine |
|
/ |
Unkown |
| HY-W075240 |
3-(4H-1,2,4-Triazol-4-yl)benzoic acid |
|
/ |
Unkown |
| HY-W075242 |
3,3'-(4-Amino-4H-1,2,4-triazole-3,5-diyl)dibenzoic acid |
|
/ |
Unkown |
| HY-W075249 |
3,3',5,5'-Tetra(1H-imidazol-1-yl)-1,1'-biphenyl |
|
/ |
Unkown |
| HY-W075259 |
3,5-Di(pyridin-2-yl)-4H-1,2,4-triazol-4-amine |
|
/ |
Unkown |
| HY-W075260 |
3,5-Di(pyridin-3-yl)-4H-1,2,4-triazol-4-amine |
|
/ |
Unkown |
| HY-W075261 |
3,5-Di(pyridin-4-yl)-4H-1,2,4-triazol-4-amine |
|
/ |
Unkown |
| HY-W075275 |
4-((1H-1,2,4-Triazol-1-yl)methyl)benzoic acid |
|
/ |
Unkown |
| HY-W075324 |
4,4'-(4-Amino-4H-1,2,4-triazole-3,5-diyl)dibenzoic acid |
|
/ |
Unkown |
| HY-W075381 |
4,4'-Di(4H-1,2,4-triazol-4-yl)-1,1'-biphenyl |
|
/ |
Unkown |
| HY-W075394 |
4,6-Di(1H-1,2,4-triazol-1-yl)isophthalic acid |
|
/ |
Unkown |
| HY-W075406 |
5-(1H-1,2,4-Triazol-1-yl)isophthalic acid |
|
/ |
Unkown |
| HY-W075451 |
5,5'-Di(1H-1,2,4-triazol-1-yl)-[1,1'-biphenyl]-3,3'-dicarboxylic acid |
|
/ |
Unkown |
| HY-W075493 |
Di(1H-1,2,4-triazol-1-yl)methane |
|
/ |
Unkown |
| HY-W075608 |
4,4'-(1H-1,2,4-Triazole-3,5-diyl)dibenzoic acid |
|
/ |
Unkown |
| HY-W075616 |
4,4'-(1-(Pyridin-4-ylmethyl)-1H-1,2,4-triazole-3,5-diyl)dipyridine |
|
/ |
Unkown |
| HY-W075617 |
4,4'-(1-Benzyl-1H-1,2,4-triazole-3,5-diyl)dipyridine |
|
/ |
Unkown |
| HY-W086270 |
2-(4-Nitrophenyl)-1H-1,3-benzodiazole-6-carboxylic acid |
|
/ |
Unkown |
| HY-W090156 |
2-(4H-1,2,4-Triazol-4-yl)acetic acid |
|
/ |
Unkown |
| HY-W090625S |
5H-Benzofuro[3,2-c]carbazole-d10 |
|
/ |
Unkown |
| HY-W1049756 |
5-(3-Ethyl-4H-1,2,4-triazol-4-yl)isophthalic acid |
|
/ |
Unkown |
| HY-W1049788 |
N1,N4-di(4H-1,2,4-triazol-4-yl)terephthalamide |
|
/ |
Unkown |
| HY-W1049790 |
2,7-Di(4H-1,2,4-triazol-4-yl)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone |
|
/ |
Unkown |
| HY-W1049795 |
1,6-di(4H-1,2,4-triazol-4-yl)hexane |
|
/ |
Unkown |
| HY-W1049797 |
(4H-1,2,4-Triazole-3,5-diyl)dimethanol |
|
/ |
Unkown |
| HY-W1049865 |
1H,1'H-[4,4'-Bipyrazole]-3,3'-diamine |
|
/ |
Unkown |
| HY-W1049879 |
4'-(1H-1,2,4-Triazol-1-yl)-[1,1'-biphenyl]-3,5-dicarboxylic acid |
|
/ |
Unkown |
| HY-W112072 |
Tris(4-(1H-1,2,4-triazol-1-yl)phenyl)amine |
|
/ |
Unkown |
| HY-W112266 |
5,5'-(1H-1,2,3-triazole-1,4-diyl)diisophthalic acid |
|
/ |
Unkown |
| HY-W112304 |
5-(4H-1,2,4-triazol-4-yl)isophthalic acid |
|
/ |
Unkown |
| HY-W112338 |
1,1′-(1,6-Hexanediyl)bis[1H-1,2,4-triazole] |
|
/ |
Unkown |
| HY-W112339 |
1,2-Di(4H-1,2,4-triazol-4-yl)ethane |
|
/ |
Unkown |
| HY-W112372 |
4,4'-Di(1H-1,2,4-triazol-1-yl)-1,1'-biphenyl |
|
/ |
Unkown |
| HY-W112382 |
4,4'-Bi-4H-1,2,4-triazole |
|
/ |
Unkown |
| HY-W112447 |
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bis[benzoic acid] |
|
/ |
Unkown |
| HY-W112459 |
4,4'-((4H-1,2,4-Triazol-4-yl)azanediyl)dibenzoic acid |
|
/ |
Unkown |
| HY-W112506 |
4-((1H-1,2,4-Triazol-3-yl)methyl)benzonitrile |
|
/ |
Unkown |
| HY-W112657 |
2,4,6-Tri(4H-1,2,4-triazol-4-yl)-1,3,5-triazine |
|
/ |
Unkown |
| HY-W112702 |
2-(1H-1,2,4-Triazol-1-yl) terephthalic acid |
|
/ |
Unkown |
| HY-W112718 |
1,1'-(9,9-Dimethyl-9H-fluorene-2,7-diyl)bis(1H-1,2,4-triazole) |
|
/ |
Unkown |
| HY-W112719 |
4,4''-Di(1H-1,2,4-triazol-1-yl)-1,1':4',1''-terphenyl |
|
/ |
Unkown |
| HY-W112720 |
1,2-Di(1H-1,2,4-triazol-1-yl)ethane |
|
/ |
Unkown |
| HY-W112754 |
1,4-Bis(1H-1,2,4-triazole-1-yl)butane |
|
/ |
Unkown |
| HY-W112756 |
1,4-Bis((4H-1,2,4-triazol-4-yl)methyl)benzene |
|
/ |
Unkown |
| HY-W112832 |
1,1'-Bis(pyridin-4-ylmethyl)-1H,1'h-2,2'-biimidazole |
|
/ |
Unkown |
| HY-W112844 |
1,1,2,2-Tetrakis(4-(1H-1,2,4-triazol-1-yl)phenyl)ethene |
|
/ |
Unkown |
| HY-W112954 |
1,3-Di(1H-1,2,4-triazol-1-yl)propane |
|
/ |
Unkown |
| HY-W112955 |
3,3'-Dimethyl-1H,1'H-4,4'-bipyrazole |
|
/ |
Unkown |
| HY-W113031 |
2-(4-(4H-1,2,4-Triazol-4-yl)phenyl)aceticacid |
|
/ |
Unkown |
| HY-W124387 |
2,3,13,14-Tetrabromo-6,7,9,10,17,18-hexahydrodibenzo[b,h][1,4,7,10,13]penta |
|
/ |
Unkown |
| HY-W124407 |
4-(4H-1,2,4-Triazol-4-yl)benzaldehyde |
|
/ |
Unkown |
| HY-W127823 |
3-Hydroxy-2-(5-hydroxypentyl)chromen-4-one |
|
/ |
Unkown |
| HY-W129041 |
6,7,9,10,17,18-Hexahydrodibenzo[b,h][1,4,7,10,13]pentaoxacyclopentadecin |
|
/ |
Unkown |
| HY-W243980 |
2-(1H-Benzo[d]imidazol-1-yl)benzoic acid |
|
/ |
Unkown |
| HY-W249138 |
4,4'-((4-(4H-1,2,4-Triazol-4-yl)phenyl)azanediyl)dibenzoic acid |
|
/ |
Unkown |
| HY-W249346 |
1,3-Di(4H-1,2,4-triazol-4-yl)benzene |
|
/ |
Unkown |
| HY-W249348 |
N1,N1,N4,N4-Tetrakis(4-(4H-1,2,4-triazol-4-yl)phenyl)benzene-1,4-diamine |
|
/ |
Unkown |
| HY-W249350 |
1,4-Di(1H-1,2,3-triazol-5-yl)benzene |
|
/ |
Unkown |
| HY-W249362 |
4,4'-(1-(Pyridin-3-ylmethyl)-1H-1,2,4-triazole-3,5-diyl)dipyridine |
|
/ |
Unkown |
| HY-W249363 |
3,4,5-Tris(4-bromophenyl)-4H-1,2,4-triazole |
|
/ |
Unkown |
| HY-W249380 |
9-Butyl-2,7-di(1H-1,2,4-triazol-1-yl)-9H-carbazole |
|
/ |
Unkown |
| HY-W249818 |
5,5',5''-(4,4',4''-(Benzene-1,3,5-triyl)tris(1H-1,2,3-triazole-4,1-diyl))triisophthalic acid |
|
/ |
Unkown |
| HY-W281862 |
Sequifenadine |
Inhibitor |
/ |
Unkown |
| HY-W291423 |
3,5-Di(pyrazin-2-yl)-4H-1,2,4-triazol-4-amine |
|
/ |
Unkown |
| HY-W354821 |
4-Methylumbelliferyl Decanoate |
|
/ |
Unkown |
| HY-W388902 |
3,5-Bis(trifluoromethyl)-4H-1,2,4-triazole |
|
/ |
Unkown |
| HY-W456303 |
3-Methyl-2-(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyridine |
|
/ |
Unkown |
| HY-W456304 |
1,4-Bis(5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)butane |
|
/ |
Unkown |
| HY-W456314 |
2,5-Bis(5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)thiophene |
|
/ |
Unkown |
| HY-W456316 |
1,3-Di(4H-1,2,4-triazol-4-yl)propane |
|
/ |
Unkown |
| HY-W456319 |
2-(5-(Pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyrazine |
|
/ |
Unkown |
| HY-W456324 |
4,4'-(5'-(4-(4H-1,2,4-Triazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(4H-1,2,4-triazole) |
|
/ |
Unkown |
| HY-W456328 |
3,5-Bis(5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)pyridine |
|
/ |
Unkown |
| HY-W456336 |
4,4'-(1H,1'H-[2,2'-Biimidazole]-1,1'-diyl)dibenzoic acid |
|
/ |
Unkown |
| HY-W456455 |
1H,1'H-3,3'-Bipyrazole |
|
/ |
Unkown |
| HY-W456471 |
3,5-Bis(5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyridine |
|
/ |
Unkown |
| HY-W456472 |
3,5-Dipropyl-4H-1,2,4-triazole |
|
/ |
Unkown |
| HY-W456473 |
1,2-Bis((1H-1,2,4-triazol-1-yl)methyl)benzene |
|
/ |
Unkown |
| HY-W456474 |
4,4'-Bis((1H-1,2,4-triazol-1-yl)methyl)-1,1'-biphenyl |
|
/ |
Unkown |
| HY-W456544 |
5-(4-((3,5-Dicarboxyphenoxy)methyl)-1H-1,2,3-triazol-1-yl)isophthalic acid |
|
/ |
Unkown |
| HY-W456586 |
1-(4-Carboxyphenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid |
|
/ |
Unkown |
| HY-W456593 |
5-(3-Methyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-4-yl)isophthalic acid |
|
/ |
Unkown |
| HY-W456595 |
5,5'-(4,4'-(Pyridine-3,5-diyl)bis(1H-1,2,3-triazole-4,1-diyl))diisophthalic acid |
|
/ |
Unkown |
| HY-W456596 |
5,5'-(4,4'-(1,3-Phenylene)bis(1H-1,2,3-triazole-4,1-diyl))diisophthalic acid |
|
/ |
Unkown |
| HY-W456597 |
5,5'-(4,4'-(1,4-Phenylene)bis(1H-1,2,3-triazole-4,1-diyl))diisophthalic acid |
|
/ |
Unkown |
| HY-W456598 |
5,5',5''-(4,4',4''-(Nitrilotris(methylene))tris(1H-1,2,3-triazole-4,1-diyl))triisophthalic acid |
|
/ |
Unkown |
| HY-W492795 |
Quifenadine hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-W543318 |
3',5'-Di(1H-1,2,4-triazol-1-yl)-[1,1'-biphenyl]-3,5-dicarboxylicacid |
|
/ |
Unkown |
| HY-W543322 |
2-(Hydroxymethyl)-2-(4H-1,2,4-triazol-4-yl)propane-1,3-diol |
|
/ |
Unkown |
| HY-W543324 |
5'-(4-(4H-1,2,4-Triazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-dicarboxylicacid |
|
/ |
Unkown |
| HY-W543325 |
4,4'-((5-(4-(4H-1,2,4-Triazol-4-yl)phenoxy)-1,3-phenylene)bis(oxy))dibenzoicacid |
|
/ |
Unkown |
| HY-W543327 |
4-(1H-1,2,3-Triazol-5-yl)benzaldehyde |
|
/ |
Unkown |
| HY-W543328 |
3,5-Bis(2-methylphenyl)-1H-1,2,4-triazole |
|
/ |
Unkown |
| HY-W543684 |
4,7-Di(1H-1,2,4-triazol-1-yl)benzo[c][1,2,5]thiadiazole |
|
/ |
Unkown |
| HY-W543752 |
3,5-Di(4H-1,2,4-triazol-4-yl)benzoic acid |
|
/ |
Unkown |
| HY-W586928 |
2-Fluoro-4-(4H-1,2,4-triazol-4-yl)benzoic acid |
|
/ |
Unkown |
| HY-W586933 |
4-(1H-1,2,4-Triazol-1-yl)-1,3-benzenedicarboxylic acid |
|
/ |
Unkown |
| HY-W588960 |
4-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)benzoic acid hydrochloride |
|
/ |
Unkown |
| HY-W653762A |
Cetirizine N-oxide dihydrochloride |
Control |
/ |
Unkown |
| HY-W660701 |
Bamipine |
|
/ |
Unkown |
| HY-W683872 |
Talastine |
Inhibitor |
/ |
Unkown |
| HY-W700970 |
Methyl 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylate |
|
/ |
Unkown |
| HY-W707972 |
Methapyrilene fumarate |
Antagonist |
/ |
Unkown |
| HY-W727488 |
2-(1H-1,2,4-Triazol-1-yl)acetic acid-d4 |
|
/ |
Unkown |
| HY-W740756 |
N-Ethyl-3,4-(methylenedioxy)aniline-d5 |
|
/ |
Unkown |
| HY-W743988 |
Cilastatin ammonium salt |
Inhibitor |
/ |
Unkown |
| HY-W744038 |
Zotepine-d6 |
|
/ |
Unkown |
| HY-W744206 |
Azelastine-d3 |
|
/ |
Unkown |
| HY-W748758 |
(Z)-Thiothixene-d8 |
|
/ |
Unkown |
| HY-W750530 |
Sodium 1H,1H,2H,2H-perfluoro hexanesulfonate-13C2 |
|
/ |
Unkown |
| HY-W750531 |
Sodium 1H,1H,2H,2H-perfluoro octanesulfonate-13C2 |
|
/ |
Unkown |
| HY-W754411 |
rac-Voriconazole-d3 |
|
/ |
Unkown |
| HY-W756792 |
1H,1H,2H,2H-Perfluorodecanesulfonic acid-13C2 sodium |
|
/ |
Unkown |
| HY-W808862 |
Ethyl 2-(3,5-di(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)acetate |
|
/ |
Unkown |
| HY-W856008 |
1,3,5-Tris((1H-1,2,4-triazol-1-yl)methyl)benzene |
|
/ |
Unkown |
| HY-W856032 |
Tris((1-(tert-butyl)-1H-1,2,3-triazol-4-yl)methyl)amine |
|
/ |
Unkown |
| HY-W856051 |
2,2'-(1H-1,2,4-Triazole-3,5-diyl)dipyridine |
|
/ |
Unkown |
| HY-W856080 |
2,6-Di(4H-1,2,4-triazol-4-yl)-3a,4,4a,7a,8,8a-hexahydro-4,8-ethenopyrrolo[3,4-f]isoindole-1,3,5,7(2H,6H)-tetraone |
|
/ |
Unkown |
| HY-W856164 |
4,4',4'',4'''-((Ethene-1,1,2,2-tetrayltetrakis(benzene-4,1-diyl))tetrakis(1H-1,2,3-triazole-4,1-diyl))tetrabenzoic acid |
|
/ |
Unkown |
| HY-W856168 |
4,4'-(5-Methyl-4H-1,2,4-triazole-3,4-diyl)bis[benzoic acid] |
|
/ |
Unkown |
| HY-W856174 |
4,4'-Bis((4H-1,2,4-triazol-4-yl)methyl)-1,1'-biphenyl |
|
/ |
Unkown |
| HY-W856203 |
5-(3,5-Dimethyl-4H-1,2,4-triazol-4-yl)-1,3-benzenedicarboxylic acid |
|
/ |
Unkown |
| HY-W856205 |
5-(3-Methyl-4H-1,2,4-triazol-4-yl)-1,3-benzenedicarboxylic acid |
|
/ |
Unkown |
| HY-W856206 |
5-(3-Methyl-5-phenyl-4H-1,2,4-triazol-4-yl)-1,3-benzenedicarboxylic acid |
|
/ |
Unkown |
| HY-W856284 |
3-Hydroxy-4-(4H-1,2,4-triazol-4-yl)benzoic acid |
|
/ |
Unkown |
| HY-W856365 |
2,6-Di(4H-1,2,4-triazol-4-yl)pyridine |
|
/ |
Unkown |
| HY-W909173 |
TAAR1 agonist 2 |
Agonist |
/ |
Unkown |
| HY-W998843 |
4-(3,5-Dimethyl-4H-1,2,4-triazol-4-yl)benzoic acid |
|
/ |
Unkown |
| HY-100661 |
Cetirizine Impurity D |
Antagonist |
/ |
Unkown |
| HY-101601 |
Bamirastine |
Inhibitor |
/ |
Unkown |
| HY-101724 |
ReN-1869 hydrochloride |
Antagonist |
/ |
Unkown |
| HY-101745 |
Rocastine |
Antagonist |
/ |
Unkown |
| HY-106161S1 |
Rupintrivir-d7 |
Inhibitor |
/ |
Unkown |
| HY-10964R |
Vadimezan (Standard) |
|
/ |
Unkown |
| HY-117146 |
Indoxacarb |
|
/ |
Unkown |
| HY-118910 |
AHR-14310C |
Antagonist |
/ |
Unkown |
| HY-120690 |
RO5464466 |
Inhibitor |
/ |
Unkown |
| HY-120765 |
BRD2879 |
Inhibitor |
/ |
Unkown |
| HY-121243 |
Halauxifen |
|
/ |
Unkown |
| HY-122166 |
Histamine receptors inhibitor 1 |
|
/ |
Unkown |
| HY-123205R |
Oxatomide (Standard) |
|
/ |
Unkown |
| HY-123437 |
WAY-120744 |
Agonist |
/ |
Unkown |
| HY-124517 |
Burimamide |
Antagonist |
/ |
Unkown |
| HY-124626 |
(R)-(+)-Mequitazine |
Inhibitor |
/ |
Unkown |
| HY-124912 |
VUF-6884 |
Inhibitor |
/ |
Unkown |
| HY-125137 |
(R)-(-)-Chlorpheniramine maleate |
Antagonist |
/ |
Unkown |
| HY-129508 |
Amthamine |
Agonist |
/ |
Unkown |
| HY-129708 |
LU 2443 |
|
/ |
Unkown |
| HY-129783 |
Phenindamine tartrate |
Antagonist |
/ |
Unkown |
| HY-132440S |
Iso Rizatriptan-d6 |
|
/ |
Unkown |
| HY-135740 |
Diphenhydramine N-oxide |
|
/ |
Unkown |
| HY-14145 |
NBI-75043 |
Antagonist |
/ |
Unkown |
| HY-14328A |
Sonepiprazole hydrochloride |
Antagonist |
/ |
Unkown |
| HY-14447S |
Bilastine-d6 |
Antagonist |
97.12% |
Unkown |
| HY-14447S1 |
Bilastine-d4 |
Antagonist |
/ |
Unkown |
| HY-163659 |
Anti-Influenza agent 6 |
Inhibitor |
/ |
Unkown |
| HY-164430 |
Arpromidine |
Modulator |
/ |
Unkown |
| HY-165378 |
(E)-Dothiepin hydrochloride |
Inhibitor |
/ |
Unkown |
| HY-167633 |
Oxomemazine hydrochloride |
Antagonist |
/ |
Unkown |
| HY-167886 |
GA 0113 |
Antagonist |
/ |
Unkown |
| HY-168698 |
(4-(1H-1,2,3-Triazol-4-yl)phenyl)methanol |
|
/ |
Unkown |
| HY-17043S2 |
Loratadine-d4-1 |
|
/ |
Unkown |
| HY-17043S3 |
Loratadine-13C6 |
|
/ |
Unkown |
| HY-170445 |
Neuraminidase-IN-23 |
Inhibitor |
/ |
Unkown |
| HY-170685 |
1-(2H-1,3-benzodioxol-5-yl)-2-[(propan-2-yl)amino]propan-1-one hydrochloride |
|
/ |
Unkown |
| HY-175796 |
Antiviral agent 70 |
Inhibitor |
/ |
Unkown |
| HY-177543 |
5-(4-Methoxvphenol)-4-methyl-3H-1,2-dithiole-3-thione |
|
/ |
Unkown |
| HY-177791 |
vRNPs degrader-1 |
Inhibitor |
/ |
Unkown |
| HY-178366 |
PAC/NP-IN-1 |
Inhibitor |
/ |
Unkown |
| HY-178455 |
Influenza virus-IN-10 |
Inhibitor |
/ |
Unkown |
| HY-179708 |
Cbz-QFR-kbt |
Inhibitor |
/ |
Unkown |
| HY-180162 |
Influenza A virus-IN-17 |
Inhibitor |
/ |
Unkown |
| HY-180525 |
PB2-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-181915 |
PB2-IN-3 |
Inhibitor |
/ |
Unkown |
| HY-32329S |
Setiptiline-d3 |
|
/ |
Unkown |
| HY-69188S |
3,4-Dihydro-2H-benzo[b][1,4]thiazine-d2 |
|
/ |
Unkown |
| HY-A0027S |
Fenspiride-d5 hydrochloride |
Antagonist |
/ |
Unkown |
| HY-B0157S1 |
Ketotifen-d3 |
Inhibitor |
/ |
Unkown |
| HY-B0188AS |
Mianserin-d3 hydrochloride |
|
97.51% |
Unkown |
| HY-B0286S1 |
Chlorpheniramine-d4 |
|
/ |
Unkown |
| HY-B0286S2 |
Chlorpheniramine-d6 |
Antagonist |
/ |
Unkown |
| HY-B0426AS |
Olopatadine-d3 hydrochloride |
|
/ |
Unkown |
| HY-B0462D |
(S)-Azelastine |
Inhibitor |
/ |
Unkown |
| HY-B0801S4 |
Fexofenadine-d3-1 |
Antagonist |
/ |
Unkown |
| HY-B1193S |
Terfenadine-d3 |
|
/ |
Unkown |
| HY-B1397S |
Cyclizine-d3 |
Antagonist |
/ |
Unkown |
| HY-B1794S |
Thiethylperazine-d3 |
|
/ |
Unkown |
| HY-B2169S2 |
Melperone-d4 hydrochloride |
|
99.84% |
Unkown |
| HY-N14082 |
Monamycin H1 |
Inhibitor |
/ |
Unkown |
| HY-N1682 |
2,7-Dihydroxy-2H-1,4-benzoxazin-3(4H)-one |
|
/ |
Unkown |
| HY-N7423 |
Methyl isoferulate |
|
/ |
Unkown |
| HY-P5550 |
Urumin |
Inhibitor |
/ |
Unkown |
| HY-RS16383 |
OR10H1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS17179 |
Suv39h1 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS20574 |
Or10h1 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS20791 |
P3h1 Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS23629 |
Suv39h1 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS27082 |
Or10h1 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS27305 |
P3h1 Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-U00018 |
(±)-Tazifylline |
Antagonist |
/ |
Unkown |
| HY-W005435S |
2,3,4,5-Tetrahydro-1H-benzo[b]azepine-d2 |
|
/ |
Unkown |
| HY-W016622R |
Watermelon ketone (Standard) |
|
/ |
Unkown |
| HY-W587689 |
Juvenile hormone B 3 (mixture of diastereomers) |
|
/ |
Unkown |
| HY-W653762 |
Cetirizine N-oxide |
Control |
/ |
Unkown |
| HY-W679758 |
1H,1H,2H,2H-Perfluorodecanesulfonic acid |
|
/ |
Unkown |
| HY-W701635 |
Meclizine N-oxide |
Control |
/ |
Unkown |
| HY-W781963 |
7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one |
Control |
/ |
Unkown |
| HY-W811579 |
Bensuldazic acid |
Inhibitor |
/ |
Unkown |
| HY-W811579A |
Bensuldazic acid sodium |
Inhibitor |
/ |
Unkown |
| HY-Z12728 |
(R)-Azelastine |
Inhibitor |
/ |
Unkown |
| HY-Z6838 |
1-[3-(4-tert-Butylbenzoyl)propyl]-4-hydroxypiperidine |
|
/ |
Unkown |
| HY-Z9099 |
Isopromethazine hydrochloride |
|
/ |
Unkown |
| HY-Z9101 |
Promethazine sulfoxide |
Control |
/ |
Unkown |
| HY-121736 |
AGI-12026 |
|
/ |
Unkown |
| HY-P0313 |
CEF6 |
Inhibitor |
/ |
Unkown |
| HY-101690 |
QF0301B |
Antagonist |
/ |
Unkown |